In July, the Secretary of Health and Human Services announced that the federal government expects to initiate a voluntary fall vaccination program against the 2009 H1N1 flu virus. The CDC will help state and local health organizations develop the vaccination program and are working to decide the scope of the program for vaccinating Americans against the novel H1N1 pandemic influenza virus.
In this web-based dialogue the public will discuss, deliberate, and offer input as the CDC considers whether to take a “full-throttle” or a “go-easy” approach to mass vaccination, or a moderate approach somewhere in-between?
WebDialogue registrants are expected to participate on both days of the two-day dialogue. They must be willing to complete a pre- and post-knowledge survey, respond to a poll on the second day, and provide feedback through an evaluation at the conclusion of the dialogue.
Register to participate! Select a dialogue and click on the link below:
Texas Forums 
Vaccines are the most powerful public health tool for control of influenza, and the U.S. government is working closely with manufacturers to take steps in the process to manufacture a 2009 H1N1 vaccine. Working together with scientists in the public and private sector, CDC has isolated the new H1N1 virus and modified the virus so that it can be used to make hundreds of millions of doses of vaccine. Vaccine manufacturers are now using these materials to begin vaccine production. Making vaccine is a multi-step process which takes several months to complete. Candidate vaccines will be tested in clinical trials over the few months.